EPA Ignored Scientific Research Showing Monsanto’s Glyphosate Causes Cancer

An analysis from the peer-reviewed scientific journal Environmental Sciences Europe 1 shows the EPA ignored many peer-reviewed independent studies that link glyphosate to cancer in humans and instead, used research funded by Monsanto and other agrochemical companies to support the agency’s position that glyphosate is not carcinogenic.

What is Roundup?

Roundup is the most widely used herbicide in the world. Its key ingredient, glyphosate, is classified as a Group 2A carcinogen by the World Health Organization’s International Agency for Research on Cancer

Glyphosate was first registered for use in the United States in 1974. Since Roundup’s introduction that same year, over 9 million tons of the weed killer have been sprayed on crops and landscaping, in public areas such as schools and parks, as well as for home use. Global use of glyphosate has grown almost 15-fold since the 1996 introduction of Roundup Ready genetically engineered glyphosate-tolerant crops.2

Over 11,000 Lawsuits filed

To date, over 11,000 people have filed lawsuits against Monsanto, which was acquired by Bayer AG in 2018. Plaintiffs claim exposure to Roundup’s glyphosate was a significant factor in causing the to develop cancer, including non-Hodgkin lymphoma. People injured include farm workers, landscapers, school groundskeepers, and home gardeners. Exposure can be through inhalation or skin contact.

Researchers See Glyphosate Health Effects Across Generations

Researchers at Washington State University have found health problems in the second and third generation of rats who were exposed to glyphosate. In the first study of its kind, researchers observed descendants of rats exposed to glyphosate developed prostate, kidney and ovarian diseases, obesity, and birth abnormalities.3

Pilliod v. Monsanto

In May 2019, a California jury ruled that exposure to Roundup used for residential landscaping was a “substantial factor” in causing the couple to develop non-Hodgkin lymphoma. The jury awarded damages of $55 million in compensatory damages and combined damages of $159 million

DeWayne Johnson v. Monsanto

On August 10, 2018, a San Francisco jury awarded former school groundskeeper DeWayne Johnson $39 million in compensatory damages and $250 million in punitive damages in his lawsuit that alleged his use of Roundup had contributed significantly to the development of his cancer. Monsanto appealed but in October 2018, the judge ruled against Monsanto and the final amount awarded to Mr. Johnson and his family was $78.5 million.

Edwin Hardeman v. Monsanto

In March 2019, a San Francisco jury decided unanimously that Roundup was a “substantial factor” contributing to Hardeman’s non-Hodgkin lymphoma. A week later, the jury awarded $80 million to Hardeman during the damages phase of the trial, finding that Monsanto had failed to warn him and other consumers about the potential dangers posed by Roundup’s formula